Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

Cerus Corporation (CERS)

NASDAQ
Currency in USD
1.770
-0.140(-7.33%)
Closed
After Hours
1.782+0.012(+0.678%)
CERS Scorecard
Full Analysis
Analysts do not anticipate the company will be profitable this year
Fair Value
Day's Range
1.7501.890
52 wk Range
1.3752.585
Key Statistics
Edit
Prev. Close
1.91
Open
1.89
Day's Range
1.75-1.89
52 wk Range
1.375-2.585
Volume
1.02M
Average Vol. (3m)
1.47M
1-Year Change
14.37%
Book Value / Share
unlockUnlock
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CERS Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
3.900
Upside
+120.339%
Members' Sentiments
Bearish
Bullish
ProTips
Liquid assets exceed short term obligations
Show more

Cerus Corporation Company Profile

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation was incorporated in 1991 and is headquartered in Concord, California.

Compare CERS to Peers and Sector

Metrics to compare
CERS
Peers
Sector
Relationship
P/E Ratio
−18.0x−2.8x−0.7x
PEG Ratio
−0.300.000.00
Price / Book
6.6x3.7x2.6x
Price / LTM Sales
2.0x1.7x3.2x
Upside (Analyst Target)
109.4%46.6%43.2%
Fair Value Upside
Unlock−2.0%6.8%Unlock

Analysts' Recommendations

4 Buy
2 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 3.900

(+120.34% Upside)

People Also Watch

5.920
AUR
-2.31%
3.460
TNYA
-3.35%
4.310
AEVA
-4.77%
20.13
OKLO
-9.45%
4.890
ASPI
-4.12%

FAQ

What Is the Cerus (CERS) Stock Price Today?

The Cerus stock price today is 1.77

What Stock Exchange Does Cerus Trade On?

Cerus is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Cerus?

The stock symbol for Cerus is "CERS."

What Is the Cerus Market Cap?

As of today, Cerus market cap is 326.86M.

What is Cerus Earnings Per Share?

The Cerus EPS is -0.108.

What Is the Next Cerus Earnings Date?

Cerus will release its next earnings report on Feb 20, 2025.

From a Technical Analysis Perspective, Is CERS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.